Human Gene Therapy

eISSN: 1557-7422pISSN: 1043-0342

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
8.2
Eigenfactor
0.005 - 0.01
H-Index
156
Impact Factor
< 5
SJR
Q2Genetics
SNIP
1.05

Journal Specifications

Overview
  • Publisher
    MARY ANN LIEBERT, INC
  • Language
    English
  • Frequency
    Monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Central nervous system
Gene transfer
Colorectal cancer
Tumor microenvironment
Clinical trial
Virus
Mass spectrometry
Extracellular matrix
Primum non nocere
Retinal
Cell therapy
Chimeric antigen receptor
Glioblastoma
Fusion protein
Coronary heart disease
Laser-induced fluorescence
Peroxide
Adeno-associated virus
Capsid
Breast cancer

Recently Published Papers

Year-wise Publication

FAQs

Since when has Human Gene Therapy been publishing? Faqs

The Human Gene Therapy has been publishing since 1990 till date.

How frequently is the Human Gene Therapy published? Faqs

Human Gene Therapy is published Monthly.

What is the H-index. SNIP score, Citescore and SJR of Human Gene Therapy? Faqs

Human Gene Therapy has a H-index score of 156, Citescore of 8.2, SNIP score of 1.05, & SJR of Q2

Who is the publisher of Human Gene Therapy? Faqs

The publisher of Human Gene Therapy is MARY ANN LIEBERT, INC.

How can I view the journal metrics of Human Gene Therapy on editage? Faqs

For the Human Gene Therapy metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Human Gene Therapy? Faqs

The eISSN number is 1557-7422 and pISSN number is 1043-0342 for Human Gene Therapy.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Central nervous system, Gene transfer, Colorectal cancer, Tumor microenvironment, Clinical trial, Virus, Mass spectrometry, Extracellular matrix, Primum non nocere, Retinal, Cell therapy, Chimeric antigen receptor, Glioblastoma, Fusion protein, Coronary heart disease, Laser-induced fluorescence, Peroxide, Adeno-associated virus, Capsid, Breast cancer.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.